Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
RNAi Technology
RNAi
αPAK siRNA (h)
Supplier Images
Published Figures
αPAK siRNA (h)
αPAK siRNA (h) from Santa Cruz Biotechnology, Inc.
Be the first to write a review!
Citations:
(19)
Figures:
(8)
Supplier Page
Supplier Page from
Santa Cruz Biotechnology, Inc. for
αPAK siRNA (h)
Description
alphaPAK siRNA (h)
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
αPAK siRNA (h)
Company
Santa Cruz Biotechnology, Inc.
Price
$293.00
Supplier Page
View Company Product Page
Catalog Number
sc-29700
Gene Name
p21 protein (Cdc42/Rac)-activated kinase 1
Quantity
10 µM
Species
human
NCBI Full Gene Name
p21 (RAC1) activated kinase 1
NCBI Gene Aliases
IDDMSSD, PAKalpha, alpha-PAK, p65-PAK
Type
siRNA/dsRNA
Add to Compare List
Santa Cruz Biotechnology, Inc.
10410 Finnell Street
Dallas
,
Texas
75220
United States
Phone
: 1-800-457-3801
831-457-3801
Company Profile
Website:
http://www.scbt.com/
Citations (19)
(1)
Analysis of NIS Plasma Membrane Interactors Discloses Key Regulation by a SRC/RAC1/PAK1/PIP5K/EZRIN Pathway with Potential Implications for Radioiodine Re-Sensitization Therapy in Thyroid Cancer
Cancers
October 30, 2021
Faria M, Domingues R, Bugalho MJ, Silva AL, Matos P.
(2)
Therapeutic potential of IBP as an autophagy inducer for treating lung cancer via blocking PAK1/Akt/mTOR signaling
Molecular therapy oncolytics
March 26, 2021
Bu H, Tan S, Yuan B, Huang X, Jiang J, Wu Y, Jiang J, Li R.
(3)
CD100-plexin-B1 induces epithelial-mesenchymal transition of head and neck squamous cell carcinoma and promotes metastasis
Cancer letters
July 28, 2019
Zhang C, Qiao H, Guo W, Liu Y, Yang L, Liu Y, Jin B, Fu M, Wang G, Li W.
(4)
Vibrio vulnificus RtxA1 cytotoxin targets filamin A to regulate PAK1- and MAPK-dependent cytoskeleton reorganization and cell death
Emerging microbes & infections
January 1, 2019
Guo RH, Im YJ, Shin SI, Jeong K, Rhee JH, Kim YR.
(5)
Wild-type p53 enhances endothelial barrier function by mediating RAC1 signalling and RhoA inhibition
Journal of cellular and molecular medicine
March 1, 2018
Barabutis N, Dimitropoulou C, Gregory B, Catravas JD.
MD, USA). AUY‐922 was purchased from
Selleckchem
(Houston, TX, USA). P53 siRNA (
sc‐29435
), PAK siRNA (
sc‐29700
), P190RHOGAP siRNA (
sc‐44077
), PDXP siRNA (
sc‐61425
), control siRNA (
sc‐37007
) and
MDM2
antibody (
sc‐965
)
(6)
p21-activated protein kinase 1 induces the invasion of gastric cancer cells through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase-2
Oncology reports
July 1, 2017
Li LH, Wu GY, Lu YZ, Chen XH, Liu BY, Zheng MH, Cai JC.
(7)
Synergistic Activation of ERα by Estrogen and Prolactin in Breast Cancer Cells Requires Tyrosyl Phosphorylation of PAK1
Cancer research
May 1, 2016
Oladimeji P, Skerl R, Rusch C, Diakonova M.
(8)
Myricetin induces apoptosis by inhibiting P21 activated kinase 1 (PAK1) signaling cascade in hepatocellular carcinoma
Molecular and cellular biochemistry
September 1, 2015
Iyer SC, Gopal A, Halagowder D.
(9)
Association of p21-activated kinase-1 activity with aggressive tumor behavior and poor prognosis of head and neck cancer
Head & neck
July 1, 2015
Park J, Kim JM, Park JK, Huang S, Kwak SY, Ryu KA, Kong G, Park J, Koo BS.
(10)
BRAF activates and physically interacts with PAK to regulate cell motility
Endocrine-related cancer
January 1, 2014
McCarty SK, Saji M, Zhang X, Knippler CM, Kirschner LS, Fernandez S, Ringel MD.
Santa Cruz Biotechnology, Inc
.),
BRAF
-specific siRNAs (cat no.
sc-36368
,
Santa Cruz Biotechnology, Inc
.),
PAK1
-specific siRNAs (cat no.
sc-29700
,
Santa Cruz Biotechnology, Inc
.),
MEK1
-specific siRNAs (cat no.
sc-29396
,
Santa Cruz Biotechnology, Inc
(11)
Epstein-Barr virus transcytosis through polarized oral epithelial cells
Journal of virology
July 1, 2013
Tugizov SM, Herrera R, Palefsky JM.
chain (sc-35057), cell division control protein 42 homolog (
Cdc42
;
sc-29256
),
Rac-1
(
sc-36351
),
Pak1
(
sc29700
),
ARF6
(
sc-43619
), and dynamin 1/2 (
sc-43736
). As controls, unrelated (scrambled) siRNAs (
sc-37007
)
(12)
Increased expression of microRNA-221 inhibits PAK1 in endothelial progenitor cells and impairs its function via c-Raf/MEK/ERK pathway
Biochemical and biophysical research communications
February 15, 2013
Zhang X, Mao H, Chen JY, Wen S, Li D, Ye M, Lv Z.
(13)
Klotho endows hepatoma cells with resistance to anoikis via VEGFR2/PAK1 activation in hepatocellular carcinoma
PloS one
January 1, 2013
Chen L, Liu H, Liu J, Zhu Y, Xu L, He H, Zhang H, Wang S, Wu Q, Liu W,
et al
.
(14)
Rac1 signalling modulates a STAT5/BCL-6 transcriptional switch on cell-cycle-associated target gene promoters
Nucleic acids research
September 1, 2012
Barros P, Lam EW, Jordan P, Matos P.
2000 and analysed 48 h later. The siRNA oligos against BCL-6 (
sc29791
),
STAT5A
(
sc-29495
) and
PAK1
(
sc-29700
) were from
Santa Cruz Biotechnology
and a scramble control oligo (5′-AGG UAG UGU AAU CGC CUU GTT) from
(15)
Hepatitis B virus X protein confers resistance of hepatoma cells to anoikis by up-regulating and activating p21-activated kinase 1
Gastroenterology
July 1, 2012
Xu J, Liu H, Chen L, Wang S, Zhou L, Yun X, Sun L, Wen Y, Gu J.
(16)
Hepatitis B virus large surface antigen promotes liver carcinogenesis by activating the Src/PI3K/Akt pathway
Cancer research
December 15, 2011
Liu H, Xu J, Zhou L, Yun X, Chen L, Wang S, Sun L, Wen Y, Gu J.
(17)
Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion
Endocrine-related cancer
December 1, 2010
McCarty SK, Saji M, Zhang X, Jarjoura D, Fusco A, Vasko VV, Ringel MD.
Santa Cruz Biotechnology, Inc
., Santa Cruz, CA, USA) or
PAK1
,
PAK2
, and
PAK3
-pooled specific siRNAs (cat.
PAK1
:
sc-29700
,
PAK2
:
sc-26183
,
PAK3
:
sc-36181
Santa Cruz, Biotechnology, Inc
.) using Lipofectamine 2000 (Life Technologies
(18)
Rac1 signaling modulates BCL-6-mediated repression of gene transcription
Molecular and cellular biology
August 1, 2009
Barros P, Jordan P, Matos P.
oligonucleotides were from
Santa Cruz Biotechnology
(Santa Cruz, CA) with the following references: ␣PAK siRNA (
sc29700
), ␥PAK (
sc36183
), BCL-6 (
sc29791
), and scramble control oligonucleotide (5⬘-AGG UAG UGU AAU CGC CUU
(19)
RNAi screen reveals an Abl kinase-dependent host cell pathway involved in Pseudomonas aeruginosa internalization
PLoS pathogens
March 21, 2008
Pielage JF, Powell KR, Kalman D, Engel JN.
Santa Cruz Biotechnology
:
Abl
(
sc-29843
),
CrkII
(
sc-37072
),
Cdc42
(
sc-29256
),
Rac1
(
sc-36351
),
Pak1
(
sc-29700
) and control siRNA (
sc-37007
).
HeLa cells
were
transfected
with siRNAs according to the manufacturer's
<<
<
>
>>
Reviews
Be the First to Write a Review!
αPAK siRNA (h) from Santa Cruz Biotechnology, Inc.
Supplier Page
View Company Product Page
$293.00
Product Specs
Company Info
Citations
Reviews
Back To Top